Most lately, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to your wide array of endogenous opioids. Unlike most opioid receptors, this receptor acts to be a scavenger and will not activate a 2nd messenger … Read More